InvestorsHub Logo

roadkilll

01/23/24 3:32 PM

#420725 RE: roadkilll #420724

Maybe Judge Du had too limited of an understanding of Vascepa? Her ignorant statement
"In February 2020 (within a month of her verdict), Judge Du made the following statement during an interview with the Nevada Lawyer magazine.

“I get tutored on varied technical issues involved in patent cases such as
learning how tasers work or the benefits of fish oil.”

* Did Du think she ruled on "fish oil"? Cost Amarin billions in sales because Du was simply too lazy to do the homework to fully understand THE REDUCE IT trial was for CV protection indication. Did Du ever really understand that Vascepa was not "Fish Oil". Most experts were surprised by Du's incomplete ruling that allowed gross infringement primary use label. Jury Trial please.

JRoon71

01/23/24 3:48 PM

#420727 RE: roadkilll #420724

But who do you sue?

The makers?
The insurers?
The pharmacies?
The doctors?

We don't even know what happened with the Healthnet case. We WON (settled), but apparently it didn't have a lot of teeth.